Zobrazeno 1 - 10
of 246
pro vyhledávání: '"Feron L"'
Autor:
Kettle JG; Oncology R&D, AstraZeneca, Cambridge CB4 0WG, U.K., Bagal SK; Oncology R&D, AstraZeneca, Cambridge CB4 0WG, U.K., Bickerton S; Oncology R&D, AstraZeneca, Cambridge CB4 0WG, U.K., Bodnarchuk MS; Oncology R&D, AstraZeneca, Cambridge CB4 0WG, U.K., Boyd S; Oncology R&D, AstraZeneca, Cambridge CB4 0WG, U.K., Breed J; Discovery Sciences, R&D, AstraZeneca, Cambridge CB4 0WG, U.K., Carbajo RJ; Oncology R&D, AstraZeneca, Cambridge CB4 0WG, U.K., Cassar DJ; Oncology R&D, AstraZeneca, Cambridge CB4 0WG, U.K., Chakraborty A; Oncology R&D, AstraZeneca, Cambridge CB4 0WG, U.K., Cosulich S; Oncology R&D, AstraZeneca, Cambridge CB4 0WG, U.K., Cumming I; Oncology R&D, AstraZeneca, Cambridge CB4 0WG, U.K., Davies M; Oncology R&D, AstraZeneca, Cambridge CB4 0WG, U.K., Davies NL; Oncology R&D, AstraZeneca, Cambridge CB4 0WG, U.K., Eatherton A; Oncology R&D, AstraZeneca, Cambridge CB4 0WG, U.K., Evans L; Oncology R&D, AstraZeneca, Cambridge CB4 0WG, U.K., Feron L; Oncology R&D, AstraZeneca, Cambridge CB4 0WG, U.K., Fillery S; Oncology R&D, AstraZeneca, Cambridge CB4 0WG, U.K., Gleave ES; Discovery Sciences, R&D, AstraZeneca, Cambridge CB4 0WG, U.K., Goldberg FW; Oncology R&D, AstraZeneca, Cambridge CB4 0WG, U.K., Hanson L; Oncology R&D, AstraZeneca, Alderley Park SK10 4TG, U.K., Harlfinger S; Oncology R&D, AstraZeneca, Cambridge CB4 0WG, U.K., Howard M; Oncology R&D, AstraZeneca, Cambridge CB4 0WG, U.K., Howells R; Oncology R&D, AstraZeneca, Cambridge CB4 0WG, U.K., Jackson A; Discovery Sciences, R&D, AstraZeneca, Cambridge CB4 0WG, U.K., Kemmitt P; Oncology R&D, AstraZeneca, Cambridge CB4 0WG, U.K., Lamont G; Oncology R&D, AstraZeneca, Cambridge CB4 0WG, U.K., Lamont S; Oncology R&D, AstraZeneca, Cambridge CB4 0WG, U.K., Lewis HJ; Oncology R&D, AstraZeneca, Cambridge CB4 0WG, U.K., Liu L; Pharmaron Beijing Co., Ltd., 6 Taihe Road BDA, Beijing 100176, P. R. China., Niedbala MJ; Oncology R&D, AstraZeneca, Waltham, Massachusetts 02451, United States., Phillips C; Discovery Sciences, R&D, AstraZeneca, Cambridge CB4 0WG, U.K., Polanski R; Discovery Sciences, R&D, AstraZeneca, Cambridge CB4 0WG, U.K., Raubo P; Oncology R&D, AstraZeneca, Cambridge CB4 0WG, U.K., Robb G; Oncology R&D, AstraZeneca, Cambridge CB4 0WG, U.K., Robinson DM; Oncology R&D, AstraZeneca, Cambridge CB4 0WG, U.K., Ross S; Oncology R&D, AstraZeneca, Cambridge CB4 0WG, U.K., Sanders MG; Oncology R&D, AstraZeneca, Cambridge CB4 0WG, U.K., Tonge M; Discovery Sciences, R&D, AstraZeneca, Cambridge CB4 0WG, U.K., Whiteley R; Oncology R&D, AstraZeneca, Cambridge CB4 0WG, U.K., Wilkinson S; Oncology R&D, AstraZeneca, Cambridge CB4 0WG, U.K., Yang J; Pharmaron Beijing Co., Ltd., 6 Taihe Road BDA, Beijing 100176, P. R. China., Zhang W; Pharmaron Beijing Co., Ltd., 6 Taihe Road BDA, Beijing 100176, P. R. China.
Publikováno v:
Journal of medicinal chemistry [J Med Chem] 2022 May 12; Vol. 65 (9), pp. 6940-6952. Date of Electronic Publication: 2022 Apr 26.
Autor:
Kettle JG; Oncology R&D, AstraZeneca, Cambridge CB4 0WG, U.K., Bagal SK; Oncology R&D, AstraZeneca, Cambridge CB4 0WG, U.K., Bickerton S; Oncology R&D, AstraZeneca, Cambridge CB4 0WG, U.K., Bodnarchuk MS; Oncology R&D, AstraZeneca, Cambridge CB4 0WG, U.K., Breed J; Discovery Sciences, R&D, AstraZeneca, Cambridge CB4 0WG, U.K., Carbajo RJ; Oncology R&D, AstraZeneca, Cambridge CB4 0WG, U.K., Cassar DJ; Oncology R&D, AstraZeneca, Cambridge CB4 0WG, U.K., Chakraborty A; Oncology R&D, AstraZeneca, Cambridge CB4 0WG, U.K., Cosulich S; Oncology R&D, AstraZeneca, Cambridge CB4 0WG, U.K., Cumming I; Oncology R&D, AstraZeneca, Cambridge CB4 0WG, U.K., Davies M; Oncology R&D, AstraZeneca, Cambridge CB4 0WG, U.K., Eatherton A; Oncology R&D, AstraZeneca, Cambridge CB4 0WG, U.K., Evans L; Oncology R&D, AstraZeneca, Cambridge CB4 0WG, U.K., Feron L; Oncology R&D, AstraZeneca, Cambridge CB4 0WG, U.K., Fillery S; Oncology R&D, AstraZeneca, Cambridge CB4 0WG, U.K., Gleave ES; Discovery Sciences, R&D, AstraZeneca, Cambridge CB4 0WG, U.K., Goldberg FW; Oncology R&D, AstraZeneca, Cambridge CB4 0WG, U.K., Harlfinger S; Oncology R&D, AstraZeneca, Cambridge CB4 0WG, U.K., Hanson L; Oncology R&D, AstraZeneca, Alderley Park SK10 4TG, U.K., Howard M; Oncology R&D, AstraZeneca, Cambridge CB4 0WG, U.K., Howells R; Oncology R&D, AstraZeneca, Cambridge CB4 0WG, U.K., Jackson A; Discovery Sciences, R&D, AstraZeneca, Cambridge CB4 0WG, U.K., Kemmitt P; Oncology R&D, AstraZeneca, Cambridge CB4 0WG, U.K., Kingston JK; Oncology R&D, AstraZeneca, Cambridge CB4 0WG, U.K., Lamont S; Oncology R&D, AstraZeneca, Cambridge CB4 0WG, U.K., Lewis HJ; Oncology R&D, AstraZeneca, Cambridge CB4 0WG, U.K., Li S; Pharmaron Beijing Co., Ltd. 6 Taihe Road BDA, Beijing 100176 P. R. China., Liu L; Pharmaron Beijing Co., Ltd. 6 Taihe Road BDA, Beijing 100176 P. R. China., Ogg D; Discovery Sciences, R&D, AstraZeneca, Cambridge CB4 0WG, U.K., Phillips C; Discovery Sciences, R&D, AstraZeneca, Cambridge CB4 0WG, U.K., Polanski R; Discovery Sciences, R&D, AstraZeneca, Cambridge CB4 0WG, U.K., Robb G; Oncology R&D, AstraZeneca, Cambridge CB4 0WG, U.K., Robinson D; Oncology R&D, AstraZeneca, Cambridge CB4 0WG, U.K., Ross S; Oncology R&D, AstraZeneca, Cambridge CB4 0WG, U.K., Smith JM; Oncology R&D, AstraZeneca, Cambridge CB4 0WG, U.K., Tonge M; Discovery Sciences, R&D, AstraZeneca, Cambridge CB4 0WG, U.K., Whiteley R; Oncology R&D, AstraZeneca, Cambridge CB4 0WG, U.K., Yang J; Pharmaron Beijing Co., Ltd. 6 Taihe Road BDA, Beijing 100176 P. R. China., Zhang L; Pharmaron Beijing Co., Ltd. 6 Taihe Road BDA, Beijing 100176 P. R. China., Zhao X; Pharmaron Beijing Co., Ltd. 6 Taihe Road BDA, Beijing 100176 P. R. China.
Publikováno v:
Journal of medicinal chemistry [J Med Chem] 2020 May 14; Vol. 63 (9), pp. 4468-4483. Date of Electronic Publication: 2020 Feb 13.
Autor:
Colarusso, Ester1 (AUTHOR) ecolarusso@unisa.it, Gazzillo, Erica1 (AUTHOR) egazzillo@unisa.it, Boccia, Eleonora1 (AUTHOR) eboccia@unisa.it, Terracciano, Stefania1 (AUTHOR) sterracciano@unisa.it, Bruno, Ines1 (AUTHOR) brunoin@unisa.it, Bifulco, Giuseppe1 (AUTHOR) bifulco@unisa.it, Chini, Maria Giovanna2 (AUTHOR) mariagiovanna.chini@unimol.it, Lauro, Gianluigi1 (AUTHOR) mariagiovanna.chini@unimol.it
Publikováno v:
Molecules. Sep2024, Vol. 29 Issue 17, p4025. 14p.
Autor:
Ward RA; Oncology and Discovery Sciences R&D , AstraZeneca , Darwin Building and Hodgkin Building, c/o Darwin Building, 310 Cambridge Science Park, Milton Rd , Cambridge CB4 0WG , U.K., Anderton MJ; Oncology and Discovery Sciences R&D , AstraZeneca , Darwin Building and Hodgkin Building, c/o Darwin Building, 310 Cambridge Science Park, Milton Rd , Cambridge CB4 0WG , U.K., Bethel P; Chemical Development, Pharmaceutical Technology & Development , AstraZeneca , Macclesfield Campus, Macclesfield SK10 2NA , U.K., Breed J; Oncology and Discovery Sciences R&D , AstraZeneca , Darwin Building and Hodgkin Building, c/o Darwin Building, 310 Cambridge Science Park, Milton Rd , Cambridge CB4 0WG , U.K., Cook C; Oncology and Discovery Sciences R&D , AstraZeneca , Darwin Building and Hodgkin Building, c/o Darwin Building, 310 Cambridge Science Park, Milton Rd , Cambridge CB4 0WG , U.K., Davies EJ; Oncology and Discovery Sciences R&D , AstraZeneca , Darwin Building and Hodgkin Building, c/o Darwin Building, 310 Cambridge Science Park, Milton Rd , Cambridge CB4 0WG , U.K., Dobson A; Chemical Development, Pharmaceutical Technology & Development , AstraZeneca , Macclesfield Campus, Macclesfield SK10 2NA , U.K., Dong Z; Pharmaron Beijing Co., Ltd. , 6 Taihe Road BDA , Beijing 100176 , P.R. China., Fairley G; Oncology and Discovery Sciences R&D , AstraZeneca , Darwin Building and Hodgkin Building, c/o Darwin Building, 310 Cambridge Science Park, Milton Rd , Cambridge CB4 0WG , U.K., Farrington P; Bioscience, Oncology R&D , AstraZeneca , Alderley Park, Macclesfield SK10 4TG , U.K., Feron L; Oncology and Discovery Sciences R&D , AstraZeneca , Darwin Building and Hodgkin Building, c/o Darwin Building, 310 Cambridge Science Park, Milton Rd , Cambridge CB4 0WG , U.K., Flemington V; Oncology and Discovery Sciences R&D , AstraZeneca , Darwin Building and Hodgkin Building, c/o Darwin Building, 310 Cambridge Science Park, Milton Rd , Cambridge CB4 0WG , U.K., Gibbons FD; DMPK, Oncology R&D , AstraZeneca , Waltham , Massachusetts 02451 , United States., Graham MA; Chemical Development, Pharmaceutical Technology & Development , AstraZeneca , Macclesfield Campus, Macclesfield SK10 2NA , U.K., Greenwood R; Oncology and Discovery Sciences R&D , AstraZeneca , Darwin Building and Hodgkin Building, c/o Darwin Building, 310 Cambridge Science Park, Milton Rd , Cambridge CB4 0WG , U.K., Hanson L; Bioscience, Oncology R&D , AstraZeneca , Alderley Park, Macclesfield SK10 4TG , U.K., Hopcroft P; Oncology and Discovery Sciences R&D , AstraZeneca , Darwin Building and Hodgkin Building, c/o Darwin Building, 310 Cambridge Science Park, Milton Rd , Cambridge CB4 0WG , U.K., Howells R; Oncology and Discovery Sciences R&D , AstraZeneca , Darwin Building and Hodgkin Building, c/o Darwin Building, 310 Cambridge Science Park, Milton Rd , Cambridge CB4 0WG , U.K., Hudson J, James M, Jones CD, Jones CR, Li Y; Pharmaron Beijing Co., Ltd. , 6 Taihe Road BDA , Beijing 100176 , P.R. China., Lamont S; Oncology and Discovery Sciences R&D , AstraZeneca , Darwin Building and Hodgkin Building, c/o Darwin Building, 310 Cambridge Science Park, Milton Rd , Cambridge CB4 0WG , U.K., Lewis R; Medicinal Chemistry, Respiratory, Inflammation and Autoimmune (RIA), BioPharmaceuticals R&D , AstraZeneca , Gothenburg 431 50 , Sweden., Lindsay N; Oncology and Discovery Sciences R&D , AstraZeneca , Darwin Building and Hodgkin Building, c/o Darwin Building, 310 Cambridge Science Park, Milton Rd , Cambridge CB4 0WG , U.K., McCabe J; Chemical Development, Pharmaceutical Technology & Development , AstraZeneca , Macclesfield Campus, Macclesfield SK10 2NA , U.K., McGuire T; Oncology and Discovery Sciences R&D , AstraZeneca , Darwin Building and Hodgkin Building, c/o Darwin Building, 310 Cambridge Science Park, Milton Rd , Cambridge CB4 0WG , U.K., Rawlins P; Oncology and Discovery Sciences R&D , AstraZeneca , Darwin Building and Hodgkin Building, c/o Darwin Building, 310 Cambridge Science Park, Milton Rd , Cambridge CB4 0WG , U.K., Roberts K; Oncology and Discovery Sciences R&D , AstraZeneca , Darwin Building and Hodgkin Building, c/o Darwin Building, 310 Cambridge Science Park, Milton Rd , Cambridge CB4 0WG , U.K., Sandin L, Simpson I, Swallow S; Chemical Development, Pharmaceutical Technology & Development , AstraZeneca , Macclesfield Campus, Macclesfield SK10 2NA , U.K., Tang J; Pharmaron Beijing Co., Ltd. , 6 Taihe Road BDA , Beijing 100176 , P.R. China., Tomkinson G; Chemical Development, Pharmaceutical Technology & Development , AstraZeneca , Macclesfield Campus, Macclesfield SK10 2NA , U.K., Tonge M; Oncology and Discovery Sciences R&D , AstraZeneca , Darwin Building and Hodgkin Building, c/o Darwin Building, 310 Cambridge Science Park, Milton Rd , Cambridge CB4 0WG , U.K., Wang Z; Pharmaron Beijing Co., Ltd. , 6 Taihe Road BDA , Beijing 100176 , P.R. China., Zhai B; Pharmaron Beijing Co., Ltd. , 6 Taihe Road BDA , Beijing 100176 , P.R. China.
Publikováno v:
Journal of medicinal chemistry [J Med Chem] 2019 Dec 26; Vol. 62 (24), pp. 11004-11018. Date of Electronic Publication: 2019 Nov 25.
Autor:
Ward RA; IMED Oncology and Discovery Sciences, AstraZeneca , Darwin Building, and AstraZeneca, Hodgkin Building, c/o Darwin Building, 310 Cambridge Science Park, Milton Road, Cambridge CB4 0WG, U.K., Bethel P; AstraZeneca , Charter Way, Macclesfield, SK10 2NA, U.K., Cook C; IMED Oncology and Discovery Sciences, AstraZeneca , Darwin Building, and AstraZeneca, Hodgkin Building, c/o Darwin Building, 310 Cambridge Science Park, Milton Road, Cambridge CB4 0WG, U.K., Davies E; IMED Oncology and Discovery Sciences, AstraZeneca , Darwin Building, and AstraZeneca, Hodgkin Building, c/o Darwin Building, 310 Cambridge Science Park, Milton Road, Cambridge CB4 0WG, U.K., Debreczeni JE; IMED Oncology and Discovery Sciences, AstraZeneca , Darwin Building, and AstraZeneca, Hodgkin Building, c/o Darwin Building, 310 Cambridge Science Park, Milton Road, Cambridge CB4 0WG, U.K., Fairley G; IMED Oncology and Discovery Sciences, AstraZeneca , Darwin Building, and AstraZeneca, Hodgkin Building, c/o Darwin Building, 310 Cambridge Science Park, Milton Road, Cambridge CB4 0WG, U.K., Feron L; IMED Oncology and Discovery Sciences, AstraZeneca , Darwin Building, and AstraZeneca, Hodgkin Building, c/o Darwin Building, 310 Cambridge Science Park, Milton Road, Cambridge CB4 0WG, U.K., Flemington V; IMED Oncology and Discovery Sciences, AstraZeneca , Darwin Building, and AstraZeneca, Hodgkin Building, c/o Darwin Building, 310 Cambridge Science Park, Milton Road, Cambridge CB4 0WG, U.K., Graham MA; AstraZeneca , Charter Way, Macclesfield, SK10 2NA, U.K., Greenwood R; IMED Oncology and Discovery Sciences, AstraZeneca , Darwin Building, and AstraZeneca, Hodgkin Building, c/o Darwin Building, 310 Cambridge Science Park, Milton Road, Cambridge CB4 0WG, U.K., Griffin N; AstraZeneca , Alderley Park, Macclesfield SK10 4TG, U.K., Hanson L; AstraZeneca , Alderley Park, Macclesfield SK10 4TG, U.K., Hopcroft P; IMED Oncology and Discovery Sciences, AstraZeneca , Darwin Building, and AstraZeneca, Hodgkin Building, c/o Darwin Building, 310 Cambridge Science Park, Milton Road, Cambridge CB4 0WG, U.K., Howard TD; AstraZeneca , Alderley Park, Macclesfield SK10 4TG, U.K., Hudson J; AstraZeneca , Alderley Park, Macclesfield SK10 4TG, U.K., James M; AstraZeneca , Alderley Park, Macclesfield SK10 4TG, U.K., Jones CD; AstraZeneca , Alderley Park, Macclesfield SK10 4TG, U.K., Jones CR; AstraZeneca , Alderley Park, Macclesfield SK10 4TG, U.K., Lamont S; IMED Oncology and Discovery Sciences, AstraZeneca , Darwin Building, and AstraZeneca, Hodgkin Building, c/o Darwin Building, 310 Cambridge Science Park, Milton Road, Cambridge CB4 0WG, U.K., Lewis R; AstraZeneca , Charter Way, Macclesfield, SK10 2NA, U.K., Lindsay N; IMED Oncology and Discovery Sciences, AstraZeneca , Darwin Building, and AstraZeneca, Hodgkin Building, c/o Darwin Building, 310 Cambridge Science Park, Milton Road, Cambridge CB4 0WG, U.K., Roberts K; IMED Oncology and Discovery Sciences, AstraZeneca , Darwin Building, and AstraZeneca, Hodgkin Building, c/o Darwin Building, 310 Cambridge Science Park, Milton Road, Cambridge CB4 0WG, U.K., Simpson I; IMED Oncology and Discovery Sciences, AstraZeneca , Darwin Building, and AstraZeneca, Hodgkin Building, c/o Darwin Building, 310 Cambridge Science Park, Milton Road, Cambridge CB4 0WG, U.K., St-Gallay S; AstraZeneca , Alderley Park, Macclesfield SK10 4TG, U.K., Swallow S; AstraZeneca , Charter Way, Macclesfield, SK10 2NA, U.K., Tang J; Pharmaron Beijing Co., Ltd. , 6 Taihe Road BDA, Beijing, 100176, P.R. China., Tonge M; IMED Oncology and Discovery Sciences, AstraZeneca , Darwin Building, and AstraZeneca, Hodgkin Building, c/o Darwin Building, 310 Cambridge Science Park, Milton Road, Cambridge CB4 0WG, U.K., Wang Z; Pharmaron Beijing Co., Ltd. , 6 Taihe Road BDA, Beijing, 100176, P.R. China., Zhai B; Pharmaron Beijing Co., Ltd. , 6 Taihe Road BDA, Beijing, 100176, P.R. China.
Publikováno v:
Journal of medicinal chemistry [J Med Chem] 2017 Apr 27; Vol. 60 (8), pp. 3438-3450. Date of Electronic Publication: 2017 Apr 14.
Autor:
Ka Iong Chan1, Siyuan Zhang1, Guodong Li1, Yida Xu1, Liao Cui2, Yitao Wang1, Huanxing Su1 huanxingsu@um.edu.mo, Wen Tan3 tanwen@lzu.edu.cn, Zhangfeng Zhong1 zfzhong@um.edu.mo
Publikováno v:
Aging & Disease. Apr2024, Vol. 15 Issue 2, p640-697. 58p.
Autor:
Bradbury RH; AstraZeneca, Mereside , Alderley Park, Macclesfield, Cheshire SK10 4TG, U.K., Callis R; AstraZeneca, Mereside , Alderley Park, Macclesfield, Cheshire SK10 4TG, U.K., Carr GR; AstraZeneca, Mereside , Alderley Park, Macclesfield, Cheshire SK10 4TG, U.K., Chen H; AstraZeneca , Gatehouse Park, Waltham, Massachusetts 02451, United States., Clark E; AstraZeneca , Gatehouse Park, Waltham, Massachusetts 02451, United States., Feron L; AstraZeneca, Mereside , Alderley Park, Macclesfield, Cheshire SK10 4TG, U.K., Glossop S; AstraZeneca, Mereside , Alderley Park, Macclesfield, Cheshire SK10 4TG, U.K., Graham MA; AstraZeneca, Mereside , Alderley Park, Macclesfield, Cheshire SK10 4TG, U.K., Hattersley M; AstraZeneca , Gatehouse Park, Waltham, Massachusetts 02451, United States., Jones C; AstraZeneca, Mereside , Alderley Park, Macclesfield, Cheshire SK10 4TG, U.K., Lamont SG; AstraZeneca, Mereside , Alderley Park, Macclesfield, Cheshire SK10 4TG, U.K., Ouvry G; AstraZeneca , Chemin du Moulin de Vrilly, 51100 Reims, France., Patel A; AstraZeneca, Mereside , Alderley Park, Macclesfield, Cheshire SK10 4TG, U.K., Patel J; AstraZeneca , Gatehouse Park, Waltham, Massachusetts 02451, United States., Rabow AA; AstraZeneca, Mereside , Alderley Park, Macclesfield, Cheshire SK10 4TG, U.K., Roberts CA; AstraZeneca, Mereside , Alderley Park, Macclesfield, Cheshire SK10 4TG, U.K., Stokes S; AstraZeneca, Mereside , Alderley Park, Macclesfield, Cheshire SK10 4TG, U.K., Stratton N; AstraZeneca, Mereside , Alderley Park, Macclesfield, Cheshire SK10 4TG, U.K., Walker GE; AstraZeneca, Mereside , Alderley Park, Macclesfield, Cheshire SK10 4TG, U.K., Ward L; AstraZeneca, Mereside , Alderley Park, Macclesfield, Cheshire SK10 4TG, U.K., Whalley D; AstraZeneca, Mereside , Alderley Park, Macclesfield, Cheshire SK10 4TG, U.K., Whittaker D; AstraZeneca, Mereside , Alderley Park, Macclesfield, Cheshire SK10 4TG, U.K., Wrigley G; AstraZeneca, Mereside , Alderley Park, Macclesfield, Cheshire SK10 4TG, U.K., Waring MJ; AstraZeneca, Mereside , Alderley Park, Macclesfield, Cheshire SK10 4TG, U.K.; Northern Institute for Cancer Research, School of Chemistry, Newcastle University , Bedson Building, Newcastle upon Tyne NE1 7RU, U.K.
Publikováno v:
Journal of medicinal chemistry [J Med Chem] 2016 Sep 08; Vol. 59 (17), pp. 7801-17. Date of Electronic Publication: 2016 Aug 24.
Autor:
Ward RA, Colclough N, Challinor M, Debreczeni JE, Eckersley K, Fairley G, Feron L, Flemington V, Graham MA, Greenwood R, Hopcroft P, Howard TD, James M, Jones CD, Jones CR, Renshaw J, Roberts K, Snow L, Tonge M, Yeung K
Publikováno v:
Journal of medicinal chemistry [J Med Chem] 2015 Jun 11; Vol. 58 (11), pp. 4790-801. Date of Electronic Publication: 2015 May 28.
Autor:
Pan, Pengming1 (AUTHOR) 2011110122@pku.edu.cn, He, Yichao1 (AUTHOR), Geng, Tongtong1 (AUTHOR), Li, Zhongtang1 (AUTHOR), Li, Zhongjun1 (AUTHOR), Meng, Xiangbao1 (AUTHOR) xbmeng@bjmu.edu.cn
Publikováno v:
International Journal of Molecular Sciences. Nov2023, Vol. 24 Issue 22, p16290. 18p.
Autor:
Kohlbauer, Sascha, Xia, Honglin, Grau, Benedikt W., Wangen, Christina, Hahn, Friedrich, Nenajdenko, Valentine G., Marschall, Manfred, Tsogoeva, Svetlana B.
Publikováno v:
Synthesis; Jan2025, Vol. 57 Issue 2, p389-396, 8p